ReviewJournal of lifestyle medicine2026
Effectiveness and Safety of Mud Therapy (Pelotherapy) for Musculoskeletal Disorders: A Systematic Review and Meta-Analysis.
Review in Journal of lifestyle medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mud therapy (pelotherapy)-the therapeutic application of natural mineral-rich mud, peat, or clay-is practiced in at least 40 countries as a non-pharmacological adjunct for musculoskeletal disorders (MSDs). This systematic review synthesized evidence on the effectiveness and safety of pelotherapy in adults with MSDs. PubMed, CENTRAL, Embase, CINAHL, Scopus, LILACS, SCI, and SSCI were searched from inception to April 2026 without language restrictions. Randomized and controlled clinical trials comparing pelotherapy with sham, usual care, or no treatment in adults with confirmed MSDs were eligible. Two reviewers independently conducted screening, data extraction, and risk-of-bias assessment using Cochrane RoB 2. Random-effects meta-analyses calculated standardized mean differences (SMDs; Hedges' g) with 95% confidence intervals (CIs), and certainty was assessed using GRADE. The protocol was prospectively registered in PROSPERO. Thirty-three studies (n = 2,651) were included in the qualitative synthesis, and 28 randomized controlled trials (n = 2,186) contributed to meta-analysis. Pelotherapy significantly reduced pain post-intervention (SMD -0.74; 95% CI -0.91 to -0.57; I
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.